THOMAS S. LIN, M.D.
Osteopathic Medicine at 10 Ave, Columbus, OH

License number
Ohio 35079473
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
W 10Th Ave, Columbus, OH 43210
Phone
(614) 947-3700
(614) 947-3771 (Fax)

Personal information

See more information about THOMAS S. LIN at radaris.com
Name
Address
Phone
Thomas Lin
8923 National Rd, Brookville, OH 45309
Thomas Lin, age 81
845 Atalan Trl, Lima, OH 45805
(419) 999-5611
Thomas Lin
7785 Fancycab Ct, Cincinnati, OH 45231
Thomas Lin
1346 Sand Run Rd, Akron, OH 44313
Thomas Lin, age 89
1611 Queens Ct, Westlake, OH 44145

Professional information

See more information about THOMAS S. LIN at trustoria.com
Thomas S Lin Photo 1
Dr. Thomas S Lin, Columbus OH - MD (Doctor of Medicine)

Dr. Thomas S Lin, Columbus OH - MD (Doctor of Medicine)

Specialties:
Hematology, Medical Oncology, Oncology
Address:
OSU Comprehensive Cancer Ctr
300 W 10Th Ave, Columbus 43210
(614) 293-8619 (Phone)
OSU Comprehensive Cancer Center
300 W 10Th Ave, Columbus 43210
(614) 293-3241 (Phone), (614) 293-4044 (Fax)
Certifications:
Hematology, 2003, Internal Medicine, 1998, Medical Oncology, 2011
Awards:
Healthgrades Honor Roll
Languages:
English, Taiwanese
Hospitals:
OSU Comprehensive Cancer Ctr
300 W 10Th Ave, Columbus 43210
OSU Comprehensive Cancer Center
300 W 10Th Ave, Columbus 43210
James Cancer Hospital and Solove Research Institute
300 West 10Th Ave, Columbus 43210
The Ohio State University Hospital East
1492 East Broad St, Columbus 43205
Wexner Medical Center at The Ohio State University
410 West 10Th Ave, Columbus 43210
Education:
Medical School
Yale University School Of Medicine
Graduated: 1995
Brigham and Women's Hospital
Graduated: 1996
Graduated: 1997
Dana Farber Cancer Institute
Graduated: 2001


Thomas S Lin Photo 2
Thomas S Lin, Columbus OH

Thomas S Lin, Columbus OH

Specialties:
Hematologist
Address:
300 W 10Th Ave, Columbus, OH 43210
Education:
Yale University, School of Medicine - Doctor of Medicine
Yale University, School of Medicine - Doctor of Philosophy
Dana-Farber Cancer Institute - Fellowship - Hematology and Oncology (Internal Medicine)
Brigham & Women's Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine), American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)


Thomas Lin Photo 3
Dosing Regimen Of Flavopiridol For Treating Cancer

Dosing Regimen Of Flavopiridol For Treating Cancer

US Patent:
2011025, Oct 13, 2011
Filed:
Dec 16, 2010
Appl. No.:
12/970550
Inventors:
Jose-Ramon SUAREZ - Neshanic Station NJ, US
John BYRD - Columbus OH, US
Michael GREVER - Powell OH, US
James DALTON - Columbus OH, US
Thomas LIN - Columbus OH, US
Assignee:
OHIO STATE UNIVERSITY RESEARCH FOUNDATION - Columbus OH
AVENTIS PHARMACEUTICALS INC. - Bridgewater NJ
International Classification:
A61K 31/453, A61P 35/00
US Classification:
514320
Abstract:
A dosing regimen comprising a therapeutically effective amount of flavopiridol or a pharmaceutically acceptable salt thereof optionally in combination with a pharmaceutically acceptable carrier suitable for bolus infusion and subsequently for infusion is disclosed and claimed. Also disclosed and claimed is a method of treating a variety of cancers in a patient comprising administering to said patient the dosing regimen of the invention.


Thomas Lin Photo 4
Dosing Regimen Of Flavopiridol For Treating Cancer`

Dosing Regimen Of Flavopiridol For Treating Cancer`

US Patent:
2008002, Jan 31, 2008
Filed:
Aug 20, 2007
Appl. No.:
11/841241
Inventors:
Jose-Ramon SUAREZ - Neshanic Station NJ, US
John BYRD - Columbus OH, US
Michael GREVER - Powell OH, US
James DALTON - Columbus OH, US
Thomas LIN - Columbus OH, US
Assignee:
AVENTIS PHARMACEUTICALS INC. - Bridgewater NJ
OHIO STATE UNIVERSITY RESEARCH FOUNDATION - Columbus OH
International Classification:
A61K 31/452
US Classification:
514320000
Abstract:
A dosing regimen comprising a therapeutically effective amount of flavopiridol or a pharmaceutically acceptable salt thereof optionally in combination with a pharmaceutically acceptable carrier suitable for bolus infusion and subsequently for infusion is disclosed and claimed. Also disclosed and claimed is a method of treating a variety of cancers in a patient comprising administering to said patient the dosing regimen of the invention.